SAN DIEGO, Jan. 3 /PRNewswire-FirstCall/ -- Diversa Corporation today announced that Edward T. Shonsey, Chief Executive Officer of Diversa Corporation, will be presenting at the JPMorgan Healthcare Conference. The presentation is scheduled to begin at 2:30 p.m. (Pacific Time) on Wednesday, January 11, and will take place at the Westin St. Francis Hotel in San Francisco. The live webcast may be accessed during the presentation and for a limited period of time following the conference through the JPMorgan website at: http://equityconferences.jpmorgan.com.
About Diversa
Diversa Corporation is a leader in applying proprietary genomic technologies for the rapid discovery and optimization of novel protein-based products. The Company is directing its integrated portfolio of technologies to the discovery, evolution, and production of commercially valuable molecules with agricultural, chemical, industrial, and pharmaceutical applications. Diversa has established alliances and joint ventures with market leaders, such as BASF, Bayer Animal Health, Cargill Health and Food Technologies, DSM Pharma Chemicals, DuPont Bio-Based Materials, Medarex, Merck, and Xoma. In addition, the Company has formed a broad strategic relationship with Syngenta AG, a world-leading agribusiness company. Diversa has commercialized products both independently and in collaboration with strategic partners and licensees. Additional information is available at Diversa's website: www.diversa.com.
Contact: Martin Sabarsky Corporate Development Diversa Corporation (858) 526-5166
Diversa CorporationCONTACT: Martin Sabarsky, Corporate Development of Diversa Corporation,+1-858-526-5166
